Comparison of mastisol (2-alpha-methylandrostan-17-beta-ol-3-one propionate) and testosterone propionate in the treatment of advanced and recurrent cancer of the breast.
D015068:17-Ketosteroids / Q000652:urine; D000328:Adult; D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D000732:Androstanols / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008875:Middle Aged; D008961:Models, Structural; D011422:Propionates; D013739:Testosterone / Q000009:adverse effects / Q000627:therapeutic use*
D015068:17-Ketosteroids; D000732:Androstanols; D011422:Propionates; D013739:Testosterone; D000469:Alkaline Phosphatase